Roivant Sciences Ltd. buy BiotechBee
Start price
24.06.23
/
60%
€9.00
Target price
31.12.25
€16.00
Performance (%)
25.44%
End price
14.12.24
€11.29
Summary
This prediction ended on 14.12.24 with a price of €11.29. The prediction had a final performance of 25.44%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Roivant Sciences Ltd. | - | - | - |
| iShares Core DAX® | 1.432% | 2.628% | 12.457% |
| iShares Nasdaq 100 | 1.892% | -0.458% | 1.248% |
| iShares Nikkei 225® | -1.619% | 11.097% | 27.382% |
| iShares S&P 500 | 1.921% | 1.159% | 1.635% |
According to BiotechBee what are the pros and cons of Roivant Sciences Ltd. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Roivant Sciences Ltd. diskutieren
Buy mit Kursziel 16,0
In the thread Trading Roivant Sciences Ltd.
Buy beendet

